Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,078.52 +37.23 (+3.58%)
Official Closing Price Updated: 4:10 PM EST, Jan 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Why Eli Lilly (LLY) Stock Is Up Today
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.5% in the afternoon session after the U.S. Food and Drug Administration (FDA) granted a Breakthrough Therapy designation for its... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Beyond the Silicon: NVIDIA and Eli Lilly Launch $1 Billion ‘Physical AI’ Lab to Rewrite the Rules of Medicine
In a move that signals the arrival of the "Bio-Computing" era, NVIDIA (NASDAQ: NVDA) and Eli Lilly (NYSE: LLY) have officially launched a landmark $1 billion AI co-innovation lab. Announced during the... 
Via TokenRing AI
Topics Artificial Intelligence Economy Intellectual Property
News headline image
J&J Forecasts $100 Billion Milestone for 2026 as Trump Drug Pricing Deals Reshape the Pharma Landscape
NEW BRUNSWICK, N.J. — In a landmark display of resilience and strategic pivoting, Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2025 revenues of $24.56 billion on Wednesday, January 21, 2026,... 
Via MarketMinute
Topics Earnings Economy Government
NVO Shares Rise On Strong Kickstart For Wegovy Pill In US: Retail Eyes Up To $110 As ‘Fair Value’ ↗
Via Stocktwits
News headline image
Eli Lilly Stock Report: Momentum, Earnings And Analyst Targets ↗
Eli Lilly's stock is experiencing short-term volatility due to its proximity to a 52-week high and upcoming earnings, amid strong analyst support and mixed technical indicators. 
Via Talk Markets
News headline image
Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how branded pharmaceuticals stocks fared in Q3, starting with... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Here&#39;s How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026? ↗
Despite a challenging year, the company has a lot to look forward to in the coming years. 
Via The Motley Fool
News headline image
Is Oral Wegovy a Game Changer for Novo Nordisk? ↗
The past couple of years have been challenging for the company. But this could be the beginning of a new chapter. 
Via The Motley Fool
News headline image
AstraZeneca Signals End of an Era: Formal Move to NYSE Triggers Major Index Rebalancing
LONDON — January 20, 2026 — In a milestone moment for global capital markets, pharmaceutical giant AstraZeneca (NYSE: AZN) has officially filed its formal notice of voluntary withdrawal from the Nasdaq... 
Via MarketMinute
Topics Regulatory Compliance
News headline image
3 Biotech Stocks That Look Like “Sure-Fire” Winners in 2026 ↗
Via MarketBeat
News headline image
Prediction: This Healthcare Stock Could Soar by 72% in 2026 ↗
And the share price appreciation could happen pretty soon. 
Via The Motley Fool
News headline image
Down 55%, Should You Buy the Dip on Pfizer? ↗
Pfizer's stock has started to turn higher, but it is still down massively; is now the time to jump aboard? 
Via The Motley Fool
Topics Intellectual Property
News headline image
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All ↗
Via MarketBeat
Topics ETFs
News headline image
Silicon Meets Science: NVIDIA and Eli Lilly Launch $1 Billion AI Lab to Engineer the Future of Medicine
In a move that signals a paradigm shift for the pharmaceutical industry, NVIDIA (NASDAQ: NVDA) and Eli Lilly and Company (NYSE: LLY) have announced the launch of a $1 billion joint AI co-innovation... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever ↗
All three of these healthcare giants are leaders in their niches. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
The Trillion-Dollar Pharmacopeia: Eli Lilly’s (LLY) Dominance in the Age of Incretins
As of January 19, 2026, the pharmaceutical landscape is being redefined by a single name: Eli Lilly and Company (NYSE: LLY). Once a steady, century-old stalwart known for its dominance in the insulin... 
Via Finterra
Topics Economy
News headline image
The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature
As of January 19, 2026, Johnson & Johnson (NYSE: JNJ) stands as a radically different enterprise than the one most investors recognized just three years ago. Following the successful spin-off of its... 
Via Finterra
Topics Artificial Intelligence Bankruptcy Economy
News headline image
Prediction: 2026 Will Be the Year of Eli Lilly ↗
A catalyst lies just ahead. 
Via The Motley Fool
News headline image
Should Investors Worry About Regional Banks After One Firm Dumped 1.8 Million Western Alliance Shares? ↗
Western Alliance Bancorporation delivers commercial and consumer banking solutions across key western U.S. markets. 
Via The Motley Fool
This Is My No. 1 Recommended Vanguard ETF to Buy in 2026 ↗
The stars could be aligning for healthcare stocks this year. This Vanguard ETF is a great way to play it. 
Via The Motley Fool
Topics ETFs Economy
News headline image
Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? ↗
The pharmaceutical leader has plenty of cash and is using it effectively. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Why a $6 Million Allocation to Short-Dated Credit Stands Out Right Now ↗
The Invesco BulletShares 2026 Corporate Bond ETF targets investment grade U.S. corporate bonds maturing in 2026 with a defined maturity profile. 
Via The Motley Fool
Topics Bonds ETFs Regulatory Compliance
News headline image
This Company Is Doubling Down on AI. Is the Stock a Buy? ↗
The pharmaceutical leader continues to grab headlines. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Eli Lilly: A Strong Player in the Pharmaceutical Arena ↗
Join us as we explore Eli Lilly's impressive market position and financial health. Discover why this pharmaceutical giant is capturing investor attention and what the future may hold for its stock. 
Via The Motley Fool
News headline image
The Atomic Revolution: How AlphaFold 3 is Redefining the Future of Medicine
In a milestone that many researchers are calling the "biological equivalent of the moon landing," AlphaFold 3 has officially moved structural biology into a new era of predictive precision. Developed... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? ↗
The choice isn't that hard. 
Via The Motley Fool
News headline image
The $5.1 Trillion Wave: Why 2026 is Set to Become the Biggest Year for Global M&A
As the global economy shakes off the final remnants of the high-interest-rate era, a massive wave of consolidation is sweeping through corporate boardrooms. Analysts have officially adjusted their... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Nvidia and Eli Lilly Are Partnering on a $1 Billion Lab. Here's What Investors Need to Know. ↗
The high-powered duo is teaming up to build and equip a $1 billion research facility in California. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Tema ETFs Adds $8 Million to an Industrial Stock Up 63% This Past Year ↗
Powell Industries designs and manufactures custom electrical systems for critical infrastructure in heavy industry and utilities worldwide. 
Via The Motley Fool
Topics ETFs Regulatory Compliance
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.